CHRNA4 and pulmonary tuberculosis: To gain insight into the impact of nAChR stimulation by ACh on bacterial burden and inflammation during pulmonary tuberculosis, mice received the α7 nAChR antagonist (MLA) and the α4β2 nAChR antagonist (DHβE) 60 days after infection.